AMNEAL PHARMACEUTICALS INC
AMRXNASDAQ🏆 #1120 by market capEarnings Oct 29US Equity
$20.20▼ $0.29 (−1.46%)
Market closed · at closeTrack AMRX
Get earnings, price moves & breaking news on Telegram
24h▼ 1.5%
7d▲ 4.4%
14d▲ 11.7%
30d▲ 15.6%
ytd▲ 60.4%
1y▲ 101.6%
🏦Market Cap
$6.45B
Small Cap
📈Revenue Growth (YoY)
+8.1%
Slowing
📊Gross Margin
39.3%
Healthy
💵FCF Margin
2.7%
Thin
⚖️P/S Ratio
2.1x
Cheap
Otter Score
64
Fair
AMNEAL PHARMACEUTICALS INC
AMRXAnalyst Ratings
Price
$20.20
Total
17
Raised
2
Lowered
1
Avg PT
$23.20
H / L
$27 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-09-17 | $20.00 | −1.00% |
UBS | Reiterated | Buy | 2026-08-03 | $25.00 | +23.80% |
Truist Securities | Reiterated | Buy | 2026-03-02 | — | — |
Piper Sandler | Reiterated | Overweight | 2025-10-31 | $11.00 | −45.50% |
JP Morgan | Reiterated | Overweight | 2025-09-16 | — | — |
Goldman Sachs | Reiterated | Buy | 2024-05-06 | $21.00 | +4.00% |
BMO Capital | Reiterated | Market Perform | 2023-03-03 | — | — |
Guggenheim | Upgraded | Neutral → Buy | 2020-12-14 | — | — |
SVB Leerink | Reiterated | Market Perform | 2020-11-09 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-13 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2020-04-02 | — | — |
RBC Capital | Reiterated | Sector Perform | 2020-01-02 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2019-12-12 | — | — |
Piper Jaffray | Upgraded | Neutral → Overweight | 2019-07-08 | — | — |
B. Riley Securities | Reiterated | Buy | 2018-08-22 | — | — |
B. Riley FBR | Reiterated | Buy | 2018-08-22 | — | — |
Canaccord Genuity | Reiterated | Hold | 2018-08-14 | — | — |
Institution
Barclays
Reiterated · Overweight · 2026-09-17
$20.00
−1.00%
UBS
Reiterated · Buy · 2026-08-03
$25.00
+23.80%
Truist Securities
Reiterated · Buy · 2026-03-02
—
—
Piper Sandler
Reiterated · Overweight · 2025-10-31
$11.00
−45.50%
JP Morgan
Reiterated · Overweight · 2025-09-16
—
—
Goldman Sachs
Reiterated · Buy · 2024-05-06
$21.00
+4.00%
BMO Capital
Reiterated · Market Perform · 2023-03-03
—
—
Guggenheim
Upgraded · Neutral → Buy · 2020-12-14
—
—
SVB Leerink
Reiterated · Market Perform · 2020-11-09
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-05-13
—
—
Morgan Stanley
Reiterated · Equal Weight · 2020-04-02
—
—
RBC Capital
Reiterated · Sector Perform · 2020-01-02
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2019-12-12
—
—
Piper Jaffray
Upgraded · Neutral → Overweight · 2019-07-08
—
—
B. Riley Securities
Reiterated · Buy · 2018-08-22
—
—
B. Riley FBR
Reiterated · Buy · 2018-08-22
—
—
Canaccord Genuity
Reiterated · Hold · 2018-08-14
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space